Testing the eligibility of glaucoma patients for potential gene therapy among a clinic population.
Carmen GruzeiJufen ZhangRupert R A BournePublished in: International ophthalmology (2022)
A substantial proportion (10%) of patients in this clinic population would meet recommended gene therapy inclusion criteria.